The Impact TDCS-linked Motor and Cognitive Training Gains in Parkinson's Disease
NCT ID: NCT04581590
Last Updated: 2025-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
242 participants
INTERVENTIONAL
2022-10-03
2026-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of EEG in Identifying Cognitive Changes in Parkinson's Disease
NCT06145776
Neuromodulation on Motor Function in Parkinson's Disease
NCT02250690
Multifocal Neuromodulation in Motor and Cognitive Function of People With Parkinson's Disease
NCT04090385
Transcranial Direct Current Stimulation (tDCS) and Virtual Reality Task in Parkinson Disease
NCT04527809
Transcranial Direct Current Stimulation and Dual Tasks
NCT05871359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Discussion: This study will evaluate the effectiveness of an intervention protocol with transcranial direct current stimulation, dual-task training and cognitive training in patients with Parkinson's disease. The study will also highlight whether the clinical factors and variability between individuals that could interfere in the training of a specific task and influence the therapeutic effect.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active group
In the group G1 will be administered: tDCS active + dual-task motor training + cognitive training.
Cognitive training
Both groups will undergo the motor training where only the type of received electric current is varied (active or simulated sham type) associated cognitive training. The twelve sessions will be performed in three sessions per week for 30 minutes.
Sham group
In the group G2 will be administered: tDCS active + dual-task motor training
Cognitive training
Both groups will undergo the motor training where only the type of received electric current is varied (active or simulated sham type) associated cognitive training. The twelve sessions will be performed in three sessions per week for 30 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive training
Both groups will undergo the motor training where only the type of received electric current is varied (active or simulated sham type) associated cognitive training. The twelve sessions will be performed in three sessions per week for 30 minutes.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 40 and 70 years, with no distinction for sex, schooling level or other sociodemographic characteristics
* disease staging between 1.5 and 3, according to the modified Hoehn and Yahr scale
* undergoing regular pharmacological treatment with levodopa (equivalent dose \> 300mg) or taking antiparkinsonian medication such as anticholinergics, selegiline, dopamine agonists (amantadine) and COMT (catechol-O-methyl transferase) inhibitors
* score of more than 24 points on the Mini-Mental State Examination
* not exhibiting other associated neurological diseases and no musculoskeletal and/or cardiorespiratory changes that could compromise gait.
Exclusion Criteria
* neuropsychiatric comorbidities; convulsions, metal clips and/or pacemaker; deep brain stimulation implant; history of epilepsy; neurosurgery; traumatic brain injury; alcohol abuse or drug dependency;
* associated diseases of the peripheral or central nervous system
* undergoing physical therapy at another location
* inability to walk 10 meters
* presence of important dyskinesia that prevents the participant from sitting in a chair
* abnormal and persistent increase in systemic blood pressure before or during training, after 3 measurements taken 5 minutes apart - Cut-off: systolic blood pressure ≥ 140 mm Hg and/or diastolic ≥ 90 mm Hg
* not understanding any of the training protocol stages
* chemical scalp treatment within the previous 30 days, and experiencing severe pain and/or discomfort that precludes performing the proposed activities.
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal do Rio Grande do Norte
OTHER
Federal University of Paraíba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Suellen Andrade
Principal Investigator and Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suellen Suellen Andrade
Role: PRINCIPAL_INVESTIGATOR
Federal University of Paraíba
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Paraíba
João Pessoa, Paraíba, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Costa-Ribeiro A, Andrade SMMDS, Ferrer MLV, Silva OAPD, Salvador MLS, Smaili S, Lindquist ARR. Can Task Specificity Impact tDCS-Linked to Dual Task Training Gains in Parkinson's Disease? A Protocol for a Randomized Controlled Trial. Front Aging Neurosci. 2021 Jul 1;13:684689. doi: 10.3389/fnagi.2021.684689. eCollection 2021.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
tDCSparkinson
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.